OncLive® On Air

S14 Ep21: Early CAR T-Cell Therapy Data Highlight Therapeutic Potential and Emerging Challenges in GI Cancers: With Kohei Shitara, MD


Listen Later

In our exclusive interview, Dr Shitara discussed preliminary efficacy data with CAR T-cell therapy in gastrointestinal cancers; highlighted challenges related to durability of response, patient selection, and manufacturing logistics with these therapies; and outlined ongoing biomarker analyses exploring tumor microenvironment factors influencing resistance.
...more
View all episodesView all episodes
Download on the App Store

OncLive® On AirBy OncLive® On Air

  • 4.2
  • 4.2
  • 4.2
  • 4.2
  • 4.2

4.2

21 ratings


More shows like OncLive® On Air

View all
Wait Wait... Don't Tell Me! by NPR

Wait Wait... Don't Tell Me!

38,759 Listeners

Marketplace Morning Report by Marketplace

Marketplace Morning Report

921 Listeners

Marketplace by Marketplace

Marketplace

8,724 Listeners

Research To Practice | Oncology Videos by Dr Neil Love

Research To Practice | Oncology Videos

116 Listeners

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast by PVI, PeerView Institute for Medical Education

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

12 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

500 Listeners

ASCO Daily News by American Society of Clinical Oncology (ASCO)

ASCO Daily News

57 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,332 Listeners

OncoPharm by John Bossaer

OncoPharm

184 Listeners

ASCO Guidelines by American Society of Clinical Oncology (ASCO)

ASCO Guidelines

44 Listeners

Lung Cancer Considered by IASLC

Lung Cancer Considered

29 Listeners

Oncology Today with Dr Neil Love by Dr. Neil Love

Oncology Today with Dr Neil Love

56 Listeners

Two Onc Docs by Sam and Karine

Two Onc Docs

185 Listeners

Oncology Brothers: Practice-Changing Cancer Discussions by Oncology Brothers

Oncology Brothers: Practice-Changing Cancer Discussions

43 Listeners

NEJM AI Grand Rounds by NEJM Group

NEJM AI Grand Rounds

58 Listeners